- $6.79bn
- $10.55bn
- $14.41bn
- 87
- 78
- 24
- 66
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9,041 | 9,150 | 11,138 | 12,651 | 14,412 |
Cost of Revenue | |||||
Gross Profit | 1,984 | 2,058 | 2,572 | 3,001 | 3,777 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8,693 | 8,550 | 10,137 | 11,386 | 12,840 |
Operating Profit | 348 | 600 | 1,001 | 1,265 | 1,572 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 261 | 562 | 944 | 1,107 | 1,334 |
Provision for Income Taxes | |||||
Net Income After Taxes | 58.5 | 374 | 836 | 811 | 1,103 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 125 | 427 | 897 | 890 | 1,171 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 125 | 427 | 897 | 890 | 1,171 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.91 | 6 | 12 | 12.3 | 17.2 |
Dividends per Share | |||||
Special Dividends per Share |